Allergan CEO Brent Saunders brushes off suggestions that the company isn’t doing enough to drive growth—and his confidence got a bit of a boost with the company’s third-quarter results. But efforts to shed its women’s health and infectious disease units aren’t progressing quite as well as he had hoped.
Reageer